Volume 33, Issue 9 (12-2025)
JSSU 2025, 33(9): 9362-9363 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Modarresi M. The Necessity of Registering Human Clinical Trial Studies in the Clinical Trial Registration System. JSSU 2025; 33 (9) :9362-9363
URL: http://jssu.ssu.ac.ir/article-1-6589-en.html
URL: http://jssu.ssu.ac.ir/article-1-6589-en.html
Abstract: (40 Views)
Abstract: Randomized clinical trials (RCTs) are the gold standard for human experimental studies. Publication Bias is one of the most important biases in RCTs that researchers have a desire to publish studies that have positive results so studies with positive findings are most likely to be published than studies with negative findings so for control of publication bias WHO oblige the researchers to submit the details of their human RCTs researches at any one of the primary registries in the WHO registry network or an ICMJE approved registry before recruitment of the first subject. Human RCTs in Iran should be registered in IRCT (http://www.irct.ir) before recruitment of the first subject and ethical code and IRCT code are necessary for publication of RCTs
Keywords: Clinical Trial Registration System
Type of Study: Letter to editor |
Subject:
other
Received: 2025/12/7 | Accepted: 2025/12/6 | Published: 2025/12/6
Received: 2025/12/7 | Accepted: 2025/12/6 | Published: 2025/12/6
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
